This is a Validated Antibody Database (VAD) review about mouse Sulf2, based on 5 published articles (read how Labome selects the articles), using Sulf2 antibody in all methods. It is aimed to help Labome visitors find the most suited Sulf2 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Sulf2 synonym: 2010004N24Rik; AU020235; MSulf-2; mKIAA1247; extracellular sulfatase Sulf-2

Novus Biologicals
mouse monoclonal (2B4)
  • western blot; human; fig 2
Novus Biologicals Sulf2 antibody (novus Biologicals, 2B4) was used in western blot on human samples (fig 2). Oncol Rep (2016) ncbi
mouse monoclonal (2B4)
  • immunohistochemistry - paraffin section; human; 2 ug/ml
  • immunohistochemistry; human
Novus Biologicals Sulf2 antibody (Novus, NBP1-36727) was used in immunohistochemistry - paraffin section on human samples at 2 ug/ml and in immunohistochemistry on human samples . BMJ Open (2012) ncbi
Bio-Rad
mouse monoclonal (2B4)
  • immunohistochemistry - paraffin section; human; 1:150; loading ...; fig 1e
Bio-Rad Sulf2 antibody (AbD Serotec, MCA5692GA) was used in immunohistochemistry - paraffin section on human samples at 1:150 (fig 1e). Br J Cancer (2016) ncbi
mouse monoclonal (2B4)
  • immunohistochemistry - paraffin section; human; 2 ug/ml
Bio-Rad Sulf2 antibody (Serotec, MCA5692T) was used in immunohistochemistry - paraffin section on human samples at 2 ug/ml. BMJ Open (2012) ncbi
R&D Systems
mouse monoclonal (2B4)
  • flow cytometry; human
R&D Systems Sulf2 antibody (R&D Systems, 2B4) was used in flow cytometry on human samples . Cancer Sci (2014) ncbi
Sigma-Aldrich
rabbit polyclonal
  • immunohistochemistry; mouse; 1:100; fig 10
In order to characterize an orthotopic xenograft mouse model and use this model to assess the effects of an anti-cancer agent, Sigma-Aldrich Sulf2 antibody (Sigma Aldrich, AV49338) was used in immunohistochemistry on mouse samples at 1:100 (fig 10). PLoS ONE (2015) ncbi
Articles Reviewed
  1. Alhasan S, Haugk B, Ogle L, Beale G, Long A, Burt A, et al. Sulfatase-2: a prognostic biomarker and candidate therapeutic target in patients with pancreatic ductal adenocarcinoma. Br J Cancer. 2016;115:797-804 pubmed publisher
  2. Zhu C, He L, Zhou X, Nie X, Gu Y. Sulfatase 2 promotes breast cancer progression through regulating some tumor-related factors. Oncol Rep. 2016;35:1318-28 pubmed publisher
  3. Coutinho de Souza P, Mallory S, Smith N, Saunders D, Li X, McNall Knapp R, et al. Inhibition of Pediatric Glioblastoma Tumor Growth by the Anti-Cancer Agent OKN-007 in Orthotopic Mouse Xenografts. PLoS ONE. 2015;10:e0134276 pubmed publisher
  4. Horiguchi H, Endo M, Miyamoto Y, Sakamoto Y, Odagiri H, Masuda T, et al. Angiopoietin-like protein 2 renders colorectal cancer cells resistant to chemotherapy by activating spleen tyrosine kinase-phosphoinositide 3-kinase-dependent anti-apoptotic signaling. Cancer Sci. 2014;105:1550-9 pubmed publisher
  5. Lui N, van Zante A, Rosen S, Jablons D, Lemjabbar Alaoui H. SULF2 expression by immunohistochemistry and overall survival in oesophageal cancer: a cohort study. BMJ Open. 2012;2: pubmed publisher